Table 1 Baseline data: participant and ulcer-related characteristics
Placebo (n = 13) | Aspirin (n = 14) | Overall (n = 27) | |
|---|---|---|---|
Participant characteristic | |||
Age | |||
Mean (SD) | 62.1 (15.2) | 62.7 (11.6) | 62.4 (13.2) |
Median (min, max) | 66.6 (38.9, 80.8) | 59.2 (47.9, 78.9) | 62.0 (38.9, 80.8) |
Gender, n (%) | |||
Male | 7 (53.9) | 11 (78.6) | 18 (66.7) |
Female | 6 (46.2) | 3 (21.4) | 9 (33.3) |
BMI | |||
Mean (SD) | 32.1 (8.6) | 36.6 (15.0) | 34.4 (12.3) |
Median (min, max) | 28.4 (19.9, 44.1) | 31.6 (20.9, 70.2) | 31.5 (19.9, 70.2) |
Ulcer related characteristics | |||
Size of ulcer (cm2) | |||
Mean (SD) | 40.7 (55.1) | 43.1 (47.6) | 42.0 (50.3) |
Median (min, max) | 16.0 (2.0, 173.0) | 31.3 (3.8, 155.0) | 17.1 (2.0, 173.0) |
≤ 5 cm2, n (%) | 3 (23.1) | 3 (21.4) | 6 (22.2) |
> 5 cm2, n (%) | 10 (76.9) | 11 (78.6) | 21 (77.8) |
Time since first ulcer (months) | |||
Mean (SD) | 112.5 (78.5) | 86.4 (86.9) | 99.0 (82.4) |
Median (min, max) | 101.0 (11.0, 240.0) | 48 (2.2, 240.0) | 72.0 (2.2, 240.0) |
Reference ulcer duration (months) | |||
Mean (SD) | 58.6 (73.3) | 32.2 (52.0) | 44.9 (63.3) |
Median (min, max) | 13.0 (4.0, 234.0) | 16.5 (1.8, 192.0) | 15.0 (1.8, 234.0) |
ABPI | |||
Mean (SD) | 1.1 (0.2) | 1.0 (0.1) | 1.0 (0.2) |
Median (min, max) | 1.0 (0.8, 1.5) | 1.0 (0.9, 1.3) | 1.0 (0.8, 1.5) |